Article ; Online: Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
2021 Volume 73, Issue 11, Page(s) 2144–2145
MeSH term(s) | Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Neutralizing ; Humans ; Mutation ; SARS-CoV-2 |
---|---|
Chemical Substances | Antibodies, Monoclonal, Humanized ; Antibodies, Neutralizing ; bamlanivimab (45I6OFJ8QH) |
Language | English |
Publishing date | 2021-05-19 |
Publishing country | United States |
Document type | Letter ; Comment |
ZDB-ID | 1099781-7 |
ISSN | 1537-6591 ; 1058-4838 |
ISSN (online) | 1537-6591 |
ISSN | 1058-4838 |
DOI | 10.1093/cid/ciab392 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1505: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 480: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.